MAGEA12 and cancer: We first compared gene expression between recurrent and nonrecurrent cases, and we found that recurrence was associated with higher expression of cancer/testis antigen (CTA) genes including MAGEA12, GAGE1, and GAGE2C as well as with lower expression of GZMK (Supplementary Figure 2 and Supplementary Table 2).